Ayaan A Alam

Array ( [id] => 1158407 [patent_doc_number] => 06762343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis and provide a mouse model for cancer' [patent_app_type] => B2 [patent_app_number] => 10/084621 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 13694 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762343.pdf [firstpage_image] =>[orig_patent_app_number] => 10084621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787172 [patent_doc_number] => 20030138411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Gene expression in monocytes and macrophages' [patent_app_type] => new [patent_app_number] => 10/060387 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138411.pdf [firstpage_image] =>[orig_patent_app_number] => 10060387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6559785 [patent_doc_number] => 20020164655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Protein-protein interactions in neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/973941 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27409 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164655.pdf [firstpage_image] =>[orig_patent_app_number] => 09973941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486244 [patent_doc_number] => 20020152482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis' [patent_app_type] => new [patent_app_number] => 09/973196 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7550 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20020152482.pdf [firstpage_image] =>[orig_patent_app_number] => 09973196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289205 [patent_doc_number] => 20020054876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/971675 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28392 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054876.pdf [firstpage_image] =>[orig_patent_app_number] => 09971675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242154 [patent_doc_number] => 20020045201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/970898 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28393 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045201.pdf [firstpage_image] =>[orig_patent_app_number] => 09970898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873846 [patent_doc_number] => 20020048769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/970814 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28397 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048769.pdf [firstpage_image] =>[orig_patent_app_number] => 09970814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6370571 [patent_doc_number] => 20020059653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/970666 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28406 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20020059653.pdf [firstpage_image] =>[orig_patent_app_number] => 09970666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5816291 [patent_doc_number] => 20020040484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/948904 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28365 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040484.pdf [firstpage_image] =>[orig_patent_app_number] => 09948904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6389997 [patent_doc_number] => 20020120947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Protein-protein interactions in neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 09/949143 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28391 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120947.pdf [firstpage_image] =>[orig_patent_app_number] => 09949143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838758 [patent_doc_number] => 20030036098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Axial pattern analysis utilizing organisms having defined marker patterns' [patent_app_type] => new [patent_app_number] => 09/932413 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5774 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036098.pdf [firstpage_image] =>[orig_patent_app_number] => 09932413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567476 [patent_doc_number] => 20020112253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action' [patent_app_type] => new [patent_app_number] => 09/929575 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8213 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20020112253.pdf [firstpage_image] =>[orig_patent_app_number] => 09929575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1203157 [patent_doc_number] => 06720473 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Intra-vascular administration of particles to induce pulmonary hypertension, pulmonary hypertension syndrome, and ascites in poultry' [patent_app_type] => B1 [patent_app_number] => 09/913774 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 30669 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720473.pdf [firstpage_image] =>[orig_patent_app_number] => 09913774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478260 [patent_doc_number] => 20020022719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Transgenic mice containing ubiquitin-specific protease gene disruptions' [patent_app_type] => new [patent_app_number] => 09/904181 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19329 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022719.pdf [firstpage_image] =>[orig_patent_app_number] => 09904181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1272057 [patent_doc_number] => 06653526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => 'Transgenic mice exhibiting increased susceptibility to seizures' [patent_app_type] => B2 [patent_app_number] => 09/904198 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19326 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653526.pdf [firstpage_image] =>[orig_patent_app_number] => 09904198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6161785 [patent_doc_number] => 20020148001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Transgenic mice containing CRFR2 corticotropin-releasing factor receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900700 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20452 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20020148001.pdf [firstpage_image] =>[orig_patent_app_number] => 09900700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014861 [patent_doc_number] => 06894205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Assay for toxin induced neuronal degeneration and viability in C. elegans ' [patent_app_type] => utility [patent_app_number] => 09/888233 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 18452 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894205.pdf [firstpage_image] =>[orig_patent_app_number] => 09888233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6717556 [patent_doc_number] => 20030028904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Genes involved in engulfment of dying cells and cell migration' [patent_app_type] => new [patent_app_number] => 09/881579 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23427 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20030028904.pdf [firstpage_image] =>[orig_patent_app_number] => 09881579 [rel_patent_id] =>[rel_patent_doc_number] =>)